Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07310537) titled 'Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling' on Dec. 16, 2025.
Study Type: Observational
Primary Sponsor: Erasmus Medical Center
Condition:
Colorectal Cancer (Diagnosis)
Colorectal Liver Metastasis (CRLM)
Circulating Tumor DNA (ctDNA)
Intervention:
Other: Blood Collection - TAP(R) Device
Recruitment Status: Recruiting
Date of First Enrollment: November 17, 2025
Target Sample Size: 35
Countries of Recruitment:
Netherlands
To know more, visit https://clinicaltrials.gov/study/NCT07310537
Disclaimer: Curated by HT Syndication....